βhCG and PAPP-A in First Trimester: Predictive Factors for Preeclampsia?

REFERENCES

• Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX–XIV.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005; 365:78–99.
   Google Scholar
• Lyall F. The human placental bed revisited. Placenta 2002; 23:555–562.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672–683.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Gellhaus A, Kasimir-Bauer S, Winterhager E, Kimmig R. Angiogenic factors during pregnancy: Indicators of preeclampsia. Geburtsh Frauenheilkd 2007; 67:228–235.
   Google Scholar
• Schmidt M, Dogan C, Birdir C, . Placental growth factor: A predictive marker for preeclampsia? Gynäkol Geburtshilfliche Rundsch 2009; 49:94–99.
   PubMedGoogle Scholar
• Stepan H, Jank A. Angiogenic factors and their role in pathogenesis and prediction of preeclampsia. Z Geburtshilfe Neonatol 2009; 213(3):101–105.
   PubMedGoogle Scholar
• Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13:231–237.
   PubMed Web of Science ®Google Scholar
• Lawrence JB, Oxvig C, Overgaard MT, . The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96:3149–3153.
   PubMed Web of Science ®Google Scholar
• van Kleffens M, Groffen C, Lindenbergh-Kortleve DJ, . The IGF system during fetal-placental development of the mouse. Mol Cell Endocrinol 1998; 140:129–135.
   PubMed Web of Science ®Google Scholar
• Yudkin PL, Aboualfa M, Eyre JA, Redman CWG, Wilkinson AR. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 1987; 15:4–2.
   Google Scholar
• Kang JH, Farina A, Park JH, . Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: Correlation with the week of onset and the severity. Prenat Diagn 2008; 28:704–709.
   PubMed Web of Science ®Google Scholar
• Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynaecol 2000; 107:1265–1270.
   Google Scholar
• Spencer K, Yu CKH, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first trimester maternal serum PAPP-A and free β-hCG and with second trimester uterine artery Doppler. Prenat Diagn 2005; 25:949–953.
   PubMed Web of Science ®Google Scholar
• Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol 2009; 201(4):412.e1–412.e6.
   Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008; 28:7–10.
   PubMed Web of Science ®Google Scholar
• Powers RW, Roberts JM, Cooper KM, . Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol 2005; 193:185–191.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Minekawa R, Veduta A, Romero XC, Nicolaides KH. Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn 2009; 29:753–760.
   PubMed Web of Science ®Google Scholar
• Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31:303–309.
   PubMed Web of Science ®Google Scholar
• Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005; 46:1077–1085.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, . Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649–658.
   PubMed Web of Science ®Google Scholar
• Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007; 197:244.e1–244.e8.
   Web of Science ®Google Scholar
• Taylor RN, Grimwood J, Taylor RS, Mcmaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188:177–182.
   PubMed Web of Science ®Google Scholar
• Teixeira PG, Cabral AC, Andrade SP, . Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Pregnancy 2008; 27:65–73.
   PubMed Web of Science ®Google Scholar
• Thadhani R, Mutter WP, Wolf M, . First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89:770–775.
   PubMed Web of Science ®Google Scholar
• Giguère Y, Charland M, Bujold E, . Combining biochemical and ultrasonographic markers in predicting preeclampsia: A systematic review. Clin Chem 2010; 56(3):363–374.
   Google Scholar
• Akolekar R, de Cruz J, Foidart JM, Munaut C, Nicolaides KH. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia. Prenat Diagn 2010; 30:191–197.
   PubMed Web of Science ®Google Scholar
• Baumann MU, Bersinger NA, Mohaupt MG, . First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008; 199:266.e1–266.e6.
   PubMed Web of Science ®Google Scholar
• Rana S, Karumanchi SA, Levine RJ, . Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007; 50:137–142.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn 2010; 30:293–308.
   PubMed Web of Science ®Google Scholar